End-diastolic volume

Papers on end-diastolic volume

120 papers25 new in 30 days

Thursday, November 19

Tuesday, November 17

Monday, November 9

Sunday, November 8

Nature Medicine

Semaglutide improved heart filling in obesity-related heart failure

Semaglutide improved how much the heart’s upper left chamber stretched by 5.7 percentage points versus placebo over 52 weeks in a 49-person trial substudy.Semaglutide improved how much the heart’s upper left chamber stretched by 5.7 percentage points versus placebo over 52 weeks in a 49-person trial substudy.

Heart sections compare an expanded upper chamber in dark blue-green with a smaller gray heart showing narrower chambers and thicker muscle.
Randomized trial · 49 peopleSemaglutide

Saturday, November 7

AHA Scientific Sessions 2026 Abstract

Two immune proteins linked to later heart failure risk

An observational study of adults assessed at average ages 57 and 75 linked two anti-inflammatory blood proteins to later heart failure hospitalizations.An observational study of adults assessed at average ages 57 and 75 linked two anti-inflammatory blood proteins to later heart failure hospitalizations.

Heart cross-sections beside blood cells and proteins, with an enlarged dark blue-green heart near dense proteins and a smaller gray heart near sparse proteins.
Cohort studyHeart failure

Wednesday, November 4

Thursday, October 29

Monday, October 26

ESC Congress 2026 Abstract

Chronic inflammation linked to heart changes and cardiovascular risk

Participants in the highest fifth for an inflammation marker had a 43% higher relative risk of major cardiovascular events than those in the lowest fifth.Participants in the highest fifth for an inflammation marker had a 43% higher relative risk of major cardiovascular events than those in the lowest fifth.

Heart cross-sections show a narrow cavity beside dense blood inflammation markers and a roomier gray heart beside sparse markers.
Cohort studyInflammation
ESC Congress 2026 Abstract

A heart shape measure was linked to stroke and heart failure risk

Higher values were linked to lower stroke risk (hazard ratio 0.81) but higher heart failure risk (1.28) over a median 4.4 years.Higher values were linked to lower stroke risk (hazard ratio 0.81) but higher heart failure risk (1.28) over a median 4.4 years.

A large heart chamber with disrupted muscle sits beside an intact brain; a smaller gray chamber sits beside a brain with a dark damaged patch.
Cohort · 44,075 peopleStroke
ESC Congress 2026 Abstract

Heart scan measure is linked to death and heart failure

In an observational study of 33,258 UK adults, an automated measure of heart muscle strain was linked to death, heart failure, and stroke.In an observational study of 33,258 UK adults, an automated measure of heart muscle strain was linked to death, heart failure, and stroke.

Heart cross-sections show a large open chamber beside a smaller contracted chamber, with white muscle markings and a small group of upright people.
Cohort · 33,258 peopleHeart failure
ESC Congress 2026 Abstract

Heart chamber volume changes predict a type of heart failure

A rising heart volume index carried a hazard ratio of 1.41 for preserved-ejection heart failure against 1.18 for heart failure with reduced ejection.A rising heart volume index carried a hazard ratio of 1.41 for preserved-ejection heart failure against 1.18 for heart failure with reduced ejection.

Heart sections show an enlarged upper chamber in dark blue-green beside a smaller gray heart with a compact upper chamber and a group of faceless people.
Cohort · 2,461 peopleHeart failure
ESC Congress 2026 Abstract

Empagliflozin reduced heart chamber volumes alongside other drugs

Over 36 weeks, empagliflozin reduced the heart’s main pumping chamber’s volume after contraction by 6.0 milliliters per square meter of body surface area versus placebo.Over 36 weeks, empagliflozin reduced the heart’s main pumping chamber’s volume after contraction by 6.0 milliliters per square meter of body surface area versus placebo.

Heart sections surrounded by blood cells show a dark blue-green heart with a proportionally smaller chamber beside a gray heart with a wider chamber.
Randomized trial · 105 peopleEmpagliflozin

Tuesday, October 20

Monday, October 19

Saturday, October 17

European Heart Journal Cardiovascular Pharmacotherapy

Dapagliflozin did not improve heart relaxation in small trial

A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomized trial.A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomized trial.

Figure from European Heart Journal Cardiovascular Pharmacotherapy
Randomized trial · 29 peopleDapagliflozin

Wednesday, September 30

Radiology

Cardiac MRI diastolic metrics predict heart failure risk

In 59,416 UK Biobank participants, peak early diastolic longitudinal strain rate showed the strongest association with incident heart failure, with a hazard ratio of…In 59,416 UK Biobank participants, peak early diastolic longitudinal strain rate showed the strongest association with incident heart failure, with a hazard ratio of 0.55.

Figure from Radiology
Cohort study of 59,416 peopleHeart failure

Tuesday, September 29